The Patent Finder

Beijing Molecule Science and Technology Co., Ltd.

Also on record
Records under this name other than the patents Beijing Molecule Science and Technology Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Showing 1 to 9 of 9 · Back to Beijing Molecule Science and Technology Co., Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,544,687Substituted α-piperazinyl phenylpropionic acid derivatives as hPPAR α and/or hPPAR γ agonists
Term ended
Term ended May 28, 2025 · USPTO record
Term endedTerm ended May 28, 2025USPTO record
US 8,030,323Pyrazole carboxamide derivatives, pharmaceutical compositions and its preparation
Lapsed on the fee record
Ended Oct 4, 2023 · USPTO record
Lapsed on the fee recordEnded Oct 4, 2023USPTO record
US 8,420,626Arene connected polyamine macrocyclic derivatives, preparation methods and pharmaceutical uses thereof
Lapsed on the fee record
Ended Apr 16, 2021 · USPTO record
Lapsed on the fee recordEnded Apr 16, 2021USPTO record
US 8,338,616Thiazoliums and their use for treating protein aging associated diseases
Lapsed on the fee record
Ended Dec 25, 2020 · USPTO record
Lapsed on the fee recordEnded Dec 25, 2020USPTO record
US 8,329,902Optically pure dihydropyrimidine compounds and their uses for the preparation of a medicament for treatment and prevention of viral diseases
Lapsed on the fee record
Ended Dec 11, 2020 · USPTO record
Lapsed on the fee recordEnded Dec 11, 2020USPTO record
US 8,188,091Tetrahydroquinazoline compounds and their use in preparing medicaments for treating and preventing virosis
Lapsed on the fee record
Ended May 29, 2020 · USPTO record
Lapsed on the fee recordEnded May 29, 2020USPTO record
US 8,173,643N-substituted thiomorpholine derivatives as the inhibitors of dipeptidyl peptidase IV and the pharmaceutical uses thereof
Lapsed on the fee record
Ended May 8, 2020 · USPTO record
Lapsed on the fee recordEnded May 8, 2020USPTO record
US 8,168,642Dihydropyrimidine compounds and their uses in preparation of medicaments for treating and preventing antiviral diseases
Lapsed on the fee record
Ended May 1, 2020 · USPTO record
Lapsed on the fee recordEnded May 1, 2020USPTO record
US 8,106,196Dihydropyrimidine compounds and their uses in manufacture of a medicament for treatment and prevention of viral diseases
Lapsed on the fee record
Ended Jan 31, 2020 · USPTO record
Lapsed on the fee recordEnded Jan 31, 2020USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited